IRVINE, Calif., Oct. 07, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Health Insurance Innovations, Inc. (“Health Insurance Innovations” or the “Company”) (Nasdaq:HIIQ). Investors who purchased or otherwise acquired shares from August 2, 2017 through September 11, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the November 10, 2017 lead plaintiff motion deadline.
If you purchased Health Insurance Innovations shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
According to the Complaint, throughout the Class Period, Health Insurance Innovations made false and/or misleading statements and/or failed to disclose: that the Company’s application for a third-party insurance administrators license with the Florida Office of Insurance Regulation was denied partly because of material errors and omissions; that the Florida Office of Insurance Regulation’s rejection of its application for a third-party insurance administrators license could result in its losing licenses in the other states; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information was announced, Health Insurance Innovation’s stock price fell materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may constitute Attorney Advertising in certain jurisdictions.
Contact
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]


Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 



